According to the vaccine trials status, Panacea has done phase l/ll and the trials have been completed on 100 adults between the ages of 18 and 60 years.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/czWXbwf
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Two companies are conducting trials to develop a dengue vaccine, says DG ICMR
https://ift.tt/pz8EUl4
No comments:
Post a Comment